Marengo Advances TriSTAR Pipeline with Ipsen Collaboration
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Cambridge, Massachusetts, August 4, 2026 Marengo Therapeutics has announced a major advancement in its strategic TriSTARâ„¢ collaboration with Ipsen,...
New York, New York, August 4, 2026 Nuvation Bio has announced that it will present new subgroup analyses from...
Irvine, California, August 4, 2026 Allergan Aesthetics, an AbbVie company, has announced that the U.S. Food and Drug Administration...
IRVINE, Calif., June 23, 2026 Allergan Aesthetics, an AbbVie company, announced that Health Canada has approved Boey® (trenibotulinumtoxinE) for...
